Method of administering liposomal encapsulated taxane
US6461637B1 · kind B1 · utility
9Cited by
1References
17Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 1, 2000 |
| Grant date | Oct 8, 2002 |
| Priority date | — |
| Expiry date | Sep 1, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/337
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Liposomal-encapsulated taxane or an antineoplastic derivative thereof or a mixture thereof is provided which is used to effect a therapeutically enhanced method of treating cancer. The liposomal encapsulated paclitaxel allows for administration to a patient in less than one hour.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.